Selected work

Please refer to my Google Scholar page for an up-to-date list of publications

Cancer Genomics

1. Jun T & Oh WK. Does Circulating Tumor DNA Measure Up to Prostate-Specific Antigen? JAMA Onc. 2022

2. Qing T, Jun T, Lindblad KE, Lujambio A, Marczyk M, Pusztai L, Huang KL. Diverse immune response of DNA damage repair-deficient tumors. Cell Rep Med. 2021

3. Jun T, Qing T, Dong G, Signaevski M, Hopkins JK, Frampton GM, Albacker LA, Cordon-Cardo C, Samstein R, Pusztai L, Huang KL. Cancer-specific associations of driver genes with immunotherapy outcome. bioRxiv 2020. (pre-print)

COVID-19

1. Zhang K, Jun T, Frank J, Nirenberg S, Kovatch P, Huang KL. Prediction of individual COVID-19 diagnosis using baseline demographics and lab data. Sci Rep. 2021 

2. Jun T, Nirenberg S, Weinberger T, Sharma N, Pujadas E, Cordon-Cardo C, Kovatch P, Huang KL. Analysis of sex-specific risk factors and clinical outcomes in COVID-19. Commun Med. 2021 

3. Tremblay D, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Feld J, Mascarenhas J, Troy K, Cromwell C, Dunn A, Oh WK, Naymagon L. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study. Blood. 2020

Liver disease & hepatocellular carcinoma

1. Jun T, Ozbek U, Dharmapuri S, Hardy-Abeloos C, Zhu H, Lin JY, Personeni N, Pressiani T, Nishida N, Lee PC, Lee CJ, Hildebrand H, Nimkar N, Paul S, Fessas P, Naeem M, Bettinger D, Khan U, Saeed A, Huang YH, Kudo M, Rimassa L, Marron TU, Pinato DJ, Ang C. Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma. Ther Adv Med Oncol. 2021 

2. Pinato DJ, Kaneko T, Saeed A, Pressiani T, Kaseb A, Wang Y, Szafron D, Jun T, Dharmapuri S, Naqash AR, Muzaffar M, Navaid M, Lee CJ, Bulumulle A, Yu B, Paul S, Nimkar N, Bettinger D, Hildebrand H, Abugabal YI, Ang C, Marron TU, Khan U, Personeni N, Rimassa L, Huang YH. Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade. Cancers (Basel). 2020

3. Vandromme M*, Jun T*, Perumalswami P, Dudley JT, Branch A, Li L. Automated phenotyping of patients with non-alcoholic fatty liver disease reveals clinically relevant disease subtypes. Pacific Symposium on Biosciences. 2020

4. Jun T, Hsu YC, Ogawa S, Huang YT, Yeh ML, Tseng CH, Huang CF, Tai CM, Dai CY, Huang JF, Chuang WL, Yu ML, Tanaka Y, Nguyen MH. Mac-2 binding protein glycosylation isomer as a hepatocellular carcinoma marker in patients with chronic hepatitis B or C infection. Hepatol Commun. 2019

5. Hsu YC, Jun T, Huang YT, Yeh ML, Lee CL, Ogawa S, Cho SH, Lin JT, Yu ML, Nguyen MH, Tanaka Y. Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2018 

6. Jun TW, Yeh ML, Yang JD, Chen VL, Nguyen P, Giama NH, Huang CF, Hsing AW, Dai CY, Huang JF, Chuang WL, Roberts LR, Yu ML, Nguyen MH. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma. Liver Int. 2018 

Medical education & trainee well-being

1. Jun TW, Liebert CA, Esquivel M, Cox JA, Trockel M, Katznelson L. A protected time policy to improve dental health among resident physicians. J Am Dent Assoc. 2019 

2. Gheihman G*, Jun T*, Young GJ, Liebman D, Sharma K, Brandes E, Ogur B, Hirsh DA. A review of longitudinal clinical programs in US medical schools. Med Educ Online. 2018

3. Lee S, Valtis YK, Jun T, Wang D, Zhang B, Chung EH, Yu A, Williams R, Cohen MJ. Measuring and improving student engagement in clinical training. Educ Prim Care. 2018

4. Chen CA, Park RJ, Hegde JV, Jun T, Christman MP, Yoo SM, Yamasaki A, Berhanu A, Vohra-Khullar P, Remus K, Schwartzstein RM, Weinstein AR. How we used a patient visit tracker tool to advance experiential learning in systems-based practice and quality improvement in a medical student clinic. Med Teach. 2016

Get in touch

Twitter: @tomiwjun